Four leaders of the department that provides drugs to NIH’s 200-bed hospital have been temporarily reassigned. Patient safety is not affected, spokeswoman says.
The company would declare bankruptcy and its owners, the Sackler family, would lose control of the firm that makes OxyContin.
The $572 million decision is the first to hold a drugmaker responsible for the opioid dispensing that sparked a nationwide epidemic of addiction and overdose deaths.
As a sprawling national opioid trial looms, they say babies who suffer withdrawal after birth need money earmarked to monitor their health.
If finalized, the task force’s guidelines would make screening free or low-cost.
In a filing for an enormous federal court case, drug manufacturers reject a link between legal production of painkillers and death and addiction on U.S. streets.
Merck released research showing a potent new drug, implanted in a matchstick-sized rod under the skin, holds promise for shielding people from HIV. But it is years from market.
For the second time ever, authorities are seeking to jail executives as they take a more aggressive stance against opioids.
Nearly 2,000 communities hurt by the opioid crisis are suing drug companies for staggering sums of money to cover the costs of treatment, education and law enforcement.
Leana Wen’s departure comes as the health care and reproductive rights group faces political and financial peril over its commitment to abortion services.